Navigation Links
New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015
Date:7/29/2014

Washington D.C. (PRWEB) July 29, 2014

New high priced hepatitis C drugs will increase federal spending in Medicare Part D by a projected $2.9 to $5.8 billion next year, according to a new report by the actuarial firm Milliman released today by the Pharmaceutical Care Management Association (PCMA). Milliman projects that average Part D premiums could increase by as much as 8.6 percent in 2015 as a result of high-priced hepatitis C drugs, including Sovaldi and Olysio.

The study finds that the majority of new Federal spending will come from increased federal reinsurance subsidies. Medicare payments for Part D catastrophic coverage have grown considerably faster than other components of Part D spending. According to the Medicare Payment Advisory Commission, between 2007 and 2012, payments have increased at an average annual rate of 14 percent while nearly doubling from $8 billion to $15.6 billion.

Milliman bases its cost projections on the assumption that 15 percent to 30 percent of the Medicare Part D population estimated to be infected with hepatitis C will receive an $84,000 course of treatment in 2015.

“While most payers cover about 75 percent of an enrollee's prescription drug costs, Medicare Part D covers 95 percent at high spending levels,” said PCMA President and CEO Mark Merritt. “The study shows taxpayers will bear the lion’s share of the increased drug costs for Medicare Part D beneficiaries taking hepatitis C drugs.”

Click here to read the new report.

Major findings from the report include:

  •     New hepatitis C drugs, including Sovaldi and Olysio, will increase 2015 federal spending on Medicare Part D by $2.9 to $5.8 billion for beneficiaries enrolled in Medicare Prescription Drug Plans (PDPs), an increase of $100 to $200 per beneficiary per year.
  •     Average monthly premiums for Medicare PDPs are projected to increase 4.3 percent to 8.6 percent next year as a result of new hepatitis C drugs, an increase of $17 to $33 per beneficiary per year.

Milliman’s analysis measured the impact of these new drugs on the Medicare Part D program; the study did not include the effect of the drug therapy on other medical costs.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12055727.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Milliman, FAIR Health Executives to Discuss Data-Based Rate Setting for Out-of-Network Providers in Atlantic Information Services Webinar
2. Milliman Actuaries to Identify Effective Strategies for Health Plans Amid Obama’s One-Year Delay During Upcoming AIS Webinar
3. Study: Pediatric preventive care guidelines need retooling for computerized format
4. Penn study: Incisionless transcatheter aortic valve replacement surgery cuts hospital length of stay
5. Study: Hour-long home coaching decreases re-admission, costs for Medicare patients
6. Study: Smoking may contribute to suicide risk
7. Study: Robot-assisted surgery for prostate cancer controls the disease for 10 years
8. Study: Body Dysmorphic Disorder patients have higher risk of personal and appearance-based rejection sensitivity
9. BUSM study: Obesity may be impacted by stress
10. Study: Young women with sexy social media photos seen as less competent
11. Study: Four Habits Model prepares pediatric nurses for emotionally difficult discussions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... CA (PRWEB) , ... June 23, 2017 , ... ... Belle, were recently denied entry to the JFK Virgin Atlantic lounge. , Bensko ... into a wheelchair six years ago, Bensko dedicated her life to supporting our wounded ...
(Date:6/23/2017)... ... June 23, 2017 , ... Georgia State University ... to 20. , The two-day conference is focused on advancing scientific knowledge about ... patients’ lives and eliminating racial breast cancer-related disparities. The conference theme is “Illuminating ...
(Date:6/23/2017)... ... ... American Farmer, will feature Chr. Hansen, Inc (CHR Hansen) in an upcoming ... American Farmer airs Tuesdays at 8:30aET on RFD-TV. Check your local listings for more ... in 1874 after a groundbreaking discovery of how to industrialize enzymes. Rooted in science ...
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, a locally ... business owners in North Central West Virginia, is embarking on a cooperative charity ... residents in the region. , The Stepping Stones organization offers a series of ...
(Date:6/22/2017)... San Marcos, California (PRWEB) , ... June 22, 2017 , ... ... to help spread the word about their high performance silicon wedding bands and all-purpose ... Groove Rings are the active, silicone rings designed just for you. , From the ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... , June 16, 2017 Datascope Corp. is voluntarily ... Datascope Corp. for a potential electrical test failure code.     ... PART NUMBER ... IABP CS300 IABP ... ...
(Date:6/14/2017)... , June 14, 2017  In 2016, Embodied ... Startups pitch competition and came away with $25,000 ... is described by Forbes as "entering the life of ... Association as teaching "empathy to medical professionals in an ... was recently named a finalist for the Department of ...
(Date:6/10/2017)... June 9, 2017  Shane K. Burchfield, DPM, is recognized by ... as a Podiatrist in Alabama . ... First Foot Care. He brings over 20 years of experience, as ... and healthcare, to his role. ... PC is pleased to welcome you to his practice," ...
Breaking Medicine Technology: